<!DOCTYPE document SYSTEM "rml_1_0.dtd"> 
<document filename="test_061_long_textfield.pdf" invariant="1">

<template pageSize="a4" leftMargin="72" showBoundary="1"
    author="A.N. Author"
    subject="My subject"
    title="My title"
    creator="My creator"
	displayDocTitle="1"
	duplex="Simplex"
	lang="en-US"
    >
	<pageTemplate id="main" pageSize="a4">
	<pageGraphics>
	</pageGraphics>
	<frame id="1" x1="35" y1="45" width="525" height="590"/>
	</pageTemplate>
</template>

<stylesheet>
	<initialize>
	<alias id="style.normal" value="style.Normal"/>
	</initialize>
	<paraStyle name="h1" fontName="Helvetica-BoldOblique" fontSize="16" leading="12" spaceAfter="16"/>
	<paraStyle name="italic" fontName="Helvetica-Oblique" fontSize="10" leading="12"/>
	<paraStyle name="normal" fontName="Helvetica" fontSize="10" leading="12" hyphenationLang="en_GB" hyphenationMinWordLength="5"/>
    <paraStyle name="normalb" fontName="Helvetica-Bold" parent="normal" spaceBefore="10"/>
	<paraStyle name="spaced" fontName="Helvetica" fontSize="12" leading="12" 
		spaceBefore="12" spaceAfter="12"/>
		<paraStyle 
        name="intro" 
        fontName="Helvetica" 
        fontSize="12" 
        leading="12"
        spaceAfter="12"/>
</stylesheet>

<story>
<illustration height="20cm" width="525">
                <textField x="0cm" y="3cm"
                name="LLM_summary"
                width="10000" height="15cm"
                fontSize="10"
                multiline="1"
				maxlen="10000"
                value="Tacrolimus:&#10;- Evidence from PharmGKB shows genotype GG is associated with increased risk of remaining on steroids at 1 year after transplantation when treated with prednisone and tacrolimus in people with heart transplantation as compared to genotypes AA + AG.&#10;&#10;Prednisone:&#10;"></textField>
<!--- Evidence from PharmGKB shows genotype GG is associated with increased risk of remaining on steroids at 1 year after transplantation when treated with prednisone and tacrolimus in people with heart transplantation as compared to genotypes AA + AG.&#10;&#10;Methotrexate:&#10;- Evidence from PharmGKB shows allele G is not associated with risk of Drug Toxicity due to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.&#10;- Evidence from PharmGKB shows allele G is not associated with risk of Drug Toxicity due to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.&#10;- Evidence from PharmGKB shows genotypes AA + AG are associated with decreased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.&#10;- Evidence from PharmGKB shows allele A is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.&#10;- Evidence from PharmGKB shows allele A is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.&#10;- Evidence from PharmGKB shows allele G is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.&#10;- Evidence from PharmGKB shows genotype AG is associated with increased concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.&#10;- Evidence from PharmGKB shows genotype AA is not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.&#10;- Evidence from PharmGKB shows genotypes AA + AG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.&#10;- Evidence from PharmGKB shows genotype AA is associated with increased concentrations of methotrexate in people with Burkitt Lymphoma, Lymphoma, T-Cell and Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG."></textField-->
</illustration>
</story>

</document>
